What buyers are paying for DME and medical supply businesses in the $1M–$5M revenue range — and what drives valuations up or down.
Medical equipment suppliers in the lower middle market typically trade at 3.5x–6x EBITDA, depending on revenue quality, regulatory standing, and customer diversification. Businesses with strong recurring rental income, active DMEPOS accreditation, and clean Medicare billing histories command premium multiples. Owner-dependent businesses with reimbursement risk or compliance exposure trade at the lower end.
| Practice Size | EBITDA Range | Multiple Range | Notes |
|---|---|---|---|
| Entry-Level | $300K–$500K | 3.5x–4.0x | Owner-dependent referrals, limited recurring revenue, minimal documentation, or unresolved compliance exposure. |
| Core Market | $500K–$750K | 4.0x–4.75x | Established DMEPOS accreditation, moderate recurring revenue mix, some customer concentration present. |
| Quality Business | $750K–$1.25M | 4.75x–5.5x | Diversified payer mix, strong rental and service contract revenue, documented management team, clean billing history. |
| Premium Asset | $1.25M+ | 5.5x–6.0x | Exclusive supplier agreements, high recurring revenue, transferable Medicare numbers, and no key-person dependency. |
The spread between 3.5x and 6.5x is not random. These seven factors determine where your firm lands.
Recurring Revenue Mix
High PositiveBusinesses deriving 50%+ of revenue from equipment rentals and service contracts command materially higher multiples than those reliant on one-time equipment sales.
DMEPOS Accreditation and Medicare Standing
High PositiveActive accreditation and clean Medicare/Medicaid billing history reduce buyer risk and support premium pricing; pending audits or overpayment demands are significant value killers.
Customer and Referral Concentration
High NegativeSingle hospital system or physician group exceeding 25% of revenue creates deal risk; buyers apply valuation discounts or demand earnouts to mitigate concentration exposure.
Supplier and Distribution Agreements
Moderate PositiveExclusive or preferred agreements with national medical brands that are transferable to a new owner add defensible competitive moat and support higher exit multiples.
Owner Dependency
High NegativeBusinesses where the founder controls key referral relationships or payer approvals face multiple compression; documented SOPs and tenured staff offset this risk significantly.
CMS reimbursement pressure and competitive bidding changes have made buyers increasingly selective about payer mix. PE-backed roll-up activity in home medical equipment has elevated multiples for accredited platforms with recurring revenue. SBA financing remains broadly available for qualified buyers, sustaining strong deal flow in the $1M–$4M transaction range.
Individual Operator / Search Fund
Entrepreneurship through acquisition (ETA), first-time buyers, industry-adjacent operators
What they want: Stable, transferable cash flow in a Medical Equipment Supplier. SBA-eligible business, strong recurring revenue mix, and a seller available for a 12–18 month transition.
Pros for seller
Cons for seller
PE-Backed Roll-Up Platform
Private equity consolidators building a Medical Equipment Supplier portfolio, regional or national platforms
What they want: Scale, operational quality, and geographic coverage. Strong recurring revenue mix with minimal customer and referral concentration. Clean financials, documented systems, and staff who can operate without the selling owner.
Pros for seller
Cons for seller
Strategic Acquirer
Larger Medical Equipment Supplier operators, adjacent-industry buyers adding capacity or geography
What they want: Client relationships, staff, and market position that complement existing operations. Recurring Revenue Mix is especially valuable when it fills a gap the buyer cannot build organically.
Pros for seller
Cons for seller
Midwest home medical equipment supplier with DMEPOS accreditation, 60% rental revenue, diversified referral base of 40+ physicians, and clean Medicare history.
$620K
EBITDA
4.8x
Multiple
$2.98M
Price
Southeast surgical supply distributor with exclusive regional distribution agreement, $2.1M recurring service contract revenue, and tenured five-person operations team.
$1.1M
EBITDA
5.5x
Multiple
$6.05M
Price
Northeast DME company with owner-dependent physician referrals, moderate Medicare audit exposure, and 70% one-time equipment sales revenue mix.
$410K
EBITDA
3.7x
Multiple
$1.52M
Price
EBITDA Valuation Estimator
Get your Medical Equipment Supplier business value range instantly
Industry: Medical Equipment Supplier · Multiples based on 4.0x–4.75x (Core Market)
Powered by DealFlow OS
dealflow-os.com · Free M&A tools for every stage of the deal
For Sellers: 4-Step Valuation Walkthrough
Compile three years of P&L statements and tax returns that reconcile line by line — SBA lenders and institutional buyers both require this, and any unexplained gap triggers diligence delays or price renegotiation.
Build a normalized EBITDA schedule with every add-back documented: owner W-2 above a market-rate manager salary, personal expenses, one-time items, and non-recurring costs. Undocumented add-backs get cut.
Address your customer and referral concentration before going to market — this is the most common reason Medical Equipment Supplier businesses receive offers at the low end of the 3.5x–6x range. Buyers identify it in diligence and reprice accordingly.
Quantify and document your recurring revenue mix with supporting records: contracts, renewal histories, and client revenue breakdowns. This is the primary evidence for commanding a premium multiple — have it ready before the first buyer call.
For Buyers: Validate the Asking Multiple
Request trailing 12-month and 3-year P&L with bank statement backup before making an offer. If a Medical Equipment Supplier seller cannot produce reconciled financials, that signals what the full diligence process will look like.
Verify the recurring revenue mix claims independently — pull contract copies, renewal documentation, and client-level revenue data. This is the primary driver of whether this Medical Equipment Supplier is worth 6x or 3.5x.
Assess customer and referral concentration directly: ask which revenue or client relationships depend on the current owner personally, and what the transition plan is. An exit-ready seller has already worked through this.
Model your SBA debt service against verified EBITDA before signing the LOI. At current rates, a $1M SBA 7(a) loan runs approximately $13,000/month over 10 years — the business needs at least 1.25x debt service coverage after a market-rate manager salary.
Most lower middle market DME businesses sell at 3.5x–6x EBITDA. Recurring rental revenue, clean compliance history, and diversified customers push multiples toward the higher end.
Buyers heavily scrutinize billing compliance and payer mix. Pending audits, high denial rates, or CMS exposure can reduce your multiple by 0.5x–1.5x or trigger earnout structures.
Yes. SBA 7(a) loans are commonly used for DME acquisitions meeting $300K+ EBITDA thresholds. Buyers typically inject 10–20% equity with a seller note bridging any valuation gap.
Build documented recurring revenue through rentals and service contracts, ensure DMEPOS accreditation is current and transferable, and reduce owner dependency before going to market.
More Medical Equipment Supplier Guides
DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.
No credit card required
For Buyers
For Sellers